Somaxon Pharmaceutical buy phonebroker
Start price
01.09.10
/
50%
€24.00
Target price
02.09.10
€32.00
Performance (%)
0.00%
End price
02.09.10
€24.00
Summary
This prediction ended on 02.09.10 with a price of €24.00. The BUY prediction by phonebroker closed unchanged from the start price. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Somaxon Pharmaceutical | - | - | - | - |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % | 50,28 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % | 107,46 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % | 76,35 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % | 72,62 % |
Comments by phonebroker for this prediction
In the thread Somaxon Pharmaceutical diskutieren
kaufen
Die Kaufempfehlung stützt sich auf folgede positive Nachricht.
Somaxon Pharmaceuticals landing Procter & Gamble as a marketing partner for the commercial launch of Somaxon's new sleeping pill Silenor.
(Stop Loss Kurs erreicht)